LAVAL, Québec--(BUSINESS WIRE)--#Altasciences--The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Altasciences’ clinical site in Los Angeles, California, based on results of a recent on-site inspectio
MISSISSAUGA, Ontario,--(BUSINESS WIRE)--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today an
Turnstone’s innovative approach with TIDAL-01 focuses on selecting and manufacturing the most potent tumor-reactive T-cells (Selected TILs) to overcome the limitations of current TIL-based therapies SAN DIEGO--(BUSINESS WIRE)--#SelectedTILs--Turnstone
WINNIPEG, Manitoba--(BUSINESS WIRE)--$FDGE #AgTech--Farmers Edge Inc. (“Farmers Edge” or the “Company”) (TSX: FDGE) announced today that the Company’s third quarter 2022 financial results will be released after market close on Thursday, November
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release financial and operational results for third quarter 2022 on Thursday, November 3, 2022, before markets o
PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, today presents its sales performance for the year to date and the third quarter of 2022. Sales summary1 YTD 2022
Company recognized for innovations in clinically validated cell therapy for corneal endothelial dystrophies SEATTLE, BOSTON & TOKYO--(BUSINESS WIRE)--Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regene
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the trajectory of autoimmune disease, today announced that data
AmbioPharm to provide cGMP peptide synthesis and support for clinical radiopharmaceutical manufacturing BERLIN & NORTH AUGUSTA, S.C.--(BUSINESS WIRE)--#cGMP--Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical produ
AUSTIN, Texas & SOUTH SAN FRANCISCO, Calif. & HAMILTON, Ontario--(BUSINESS WIRE)--Triumvira Immunologics (“Triumvira”), a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology o
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.